课题基金 / 基金详情

Lactation on Breast Tumorigenesis

Lactation on Breast Tumorigenesis
哺乳期对乳腺肿瘤发生的影响
批准号:
10668820
负责人:
Yi Li
金额:
$55.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-01 至 2028-04-30

项目摘要

项目成果

Yi Li的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Epidemiological studies have demonstrated that a first birth before age 25 lowers breast cancer (BCa) risk, while a first birth after age 35 increases BCa risk. This age-dependent impact of first birth on BCa risk is generally attributed to the pregnancy itself, with much less consideration for the lactation that often ensues. In young women, evidence is strong that both pregnancy itself and lactation decrease BCa risk. However, the relative contribution of pregnancy vs. lactation to increased BCa risk associated with a late-age reproduction has not been studied rigorously, either epidemiologically or experimentally. Lactation itself at any age is assumed to be beneficial to both mothers and infants, and is encouraged. However, our preliminary data suggest the hypothesis that lactation instigates preexistent early lesions to progress to cancer. Given the increasingly large population of women who choose to delay their first pregnancy to age 35 or older when the chance of having accumulated early lesions is heightened, our hypothesis, if proven, has important and immediate implications for these women and especially for women have been diagnosed with atypia. They can use this knowledge to make informed decisions regarding whether and how long they will breastfeed. We will test this hypothesis and study the underlying molecular mechanism by pursuing three aims: Specific Aim 1. To further elucidate the impact of pregnancy vs. lactation on breast cancer risk of preexistent mammary early lesions. Specific Aim 2. To investigate how lactation modulates the progression path of precancerous lesions. Specific Aim 3. To further elucidate lactation-induced changes in precancerous lesions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mutating E-cadherin in rats to model lobular breast cancer
  • 批准号:
    10830164
  • 项目类别:
  • 资助金额:
    $17.46万
  • 财政年份:
    2022
  • 负责人:
    Yi Li
  • 依托单位:
Next Generation Rat Models of ER+ Breast Cancer
  • 批准号:
    10591512
  • 项目类别:
  • 资助金额:
    $58.52万
  • 财政年份:
    2022
  • 负责人:
    Yi Li
  • 依托单位:
Next Generation Rat Models of ER+ Breast Cancer
  • 批准号:
    10464834
  • 项目类别:
  • 资助金额:
    $61.22万
  • 财政年份:
    2022
  • 负责人:
    Yi Li
  • 依托单位:
New Statistical Methods for Modelling Cancer Outcomes
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: